Novartis psoriasis drug tops J&J's Stelara in late-stage study

ZURICH (Reuters) - Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.

Source: Reuters: Health - December 12, 2014 Category: Consumer Health News Tags: healthNews Source Type: news